Bengaluru Biomedicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 08-07-2024
- Paid Up Capital ₹ 1.00 Cr
as on 08-07-2024
- Company Age 14 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.20 M
as on 08-07-2024
- Revenue -1.01%
(FY 2016)
- Profit 11.10%
(FY 2016)
- Ebitda 31.00%
(FY 2016)
- Net Worth
- Total Assets 9.54%
(FY 2016)
About Bengaluru Biomedicals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹2.20 M.
Sam Mathew and Anil Koni serve as directors at the Company.
- CIN/LLPIN
U33119KA2010PTC054780
- Company No.
054780
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Aug 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bengaluru Biomedicals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sam Mathew  | Director | 10-Oct-2012 | Current |
| Anil Koni | Director | 13-Aug-2010 | Current |
Financial Performance and Corporate Structure Insights of Bengaluru Biomedicals.
Bengaluru Biomedicals Private Limited, for the financial year ended 2016, experienced Minor drop in revenue, with a 1.01% decrease. The company also saw a substantial improvement in profitability, with a 11.1% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bengaluru Biomedicals?
In 2015, Bengaluru Biomedicals had a promoter holding of 20.00% and a public holding of 80.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
_PRIVATE_LIMITED.webp)
Emergent Medi-Tech (India) Private LimitedActive 24 years 2 monthsSam Mathew and Anil Koni are mutual person
Medical Support Systems (India) Pvt LtdActive 18 years 9 monthsSam Mathew and Anil Koni are mutual person
- Endovascular Therapeutics India Private LimitedActive 24 years 7 months
Sam Mathew is a mutual person
_PRIVATE_LIMITED.webp)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 01 Jul 2014 | ₹2.20 M | Open |
How Many Employees Work at Bengaluru Biomedicals?
Unlock and access historical data on people associated with Bengaluru Biomedicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bengaluru Biomedicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bengaluru Biomedicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
